Menu
← Oncology Approval Tracker
FDA DECISION ·
Imfinzi + platinum + etoposide
durvalumab + platinum chemotherapy + etoposide · AstraZeneca
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First-line treatment for extensive-stage small cell lung cancer using durvalumab with etoposide and carboplatin or cisplatin.
LAMPGEN ANALYSIS
Why it matters
Added checkpoint blockade to a standard first-line chemotherapy backbone in extensive-stage disease.
What research teams should watch
Coordinate infusion sequencing and the transition to durvalumab maintenance.
PRIMARY RECORDS